ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00508625
Recruitment Status : Completed
First Posted : July 30, 2007
Last Update Posted : June 14, 2016
Sponsor:
Collaborator:
Genentech, Inc.
Information provided by (Responsible Party):
Amgen

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : March 2009
  Actual Study Completion Date : November 2011
  Certification/Extension First Submitted : March 2, 2016